Immunic share price logo

Immunic

NASDAQ: IMUX

$16.84

+0.81

(+5.08%)

as on

Immunic Stock Performance

as on August 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $15.88
    $17.15
    downward going graph

    5.70%

    Downside

    1.84%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.06
    $16.86
    downward going graph

    69.94%

    Downside

    0.13%

    Upside

    downward going graph

Immunic share price movements today

Previous Close
$16.03
Open
$15.88
Volume
364.8K
Market Cap
$219.1M
Day's Low - High
$15.88 - $17.15
52 Week Low - High
$5.06 - $16.86

Immunic Historical Returns

1 Month Return
+ 5.94 %
3 Month Return
+ 32.95 %
1 Year Return
+ 78.17 %
3 Year Return
+ 0.37 %
5 Year Return
-83.34 %

Immunic Stock Fundamentals & Key Indicators

Check Immunic market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$219.1M

EPS (TTM)

-4.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.45

Industry PE ratio

-1.5966015625

PEG Ratio

-0.04234698037664933

EBITDA

-111.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-157.89%

Immunic Stock Valuation

Track how Immunic P/E has moved over time to understand its valuation trends.

Immunic in the last 5 years

  • Overview

  • Trends

Lowest (-2.44x)

December 31, 2021

Industry (-1.60x)

December 31, 2025

Today (-0.86x)

December 31, 2025

Highest (-0.37x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -0.86x

Immunic vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunic with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$219.1M-83.34%-3.450.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Immunic Stock including INR - Dollar returns

The Immunic stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunic investment value today

Current value as on today

₹2,04,706

Returns

₹1,04,706

(+104.71%)

Returns from Immunic Stock

₹86,821 (+86.82%)

Dollar Impact

₹17,886 (+17.89%)

Analyst Recommendation on Immunic Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Immunic. Average target price of $41.9

Immunic Share Price Target

Get share price movements and forecasts by analysts on Immunic.

What analysts predicted

59.81%UPSIDE

Target Price

$41.9

Current Price

$16.84

Analyzed by

8 Analysts

Target

$41.90

Immunic target price $41.9, a slight upside of 59.81% compared to current price of $16.84. According to 8 analysts rating.

Indian Investors' Interest in Immunic Stock

Search interest for Immunic Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Immunic Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
-
-
-
-
0
-
Operating Income
-23
-22
-25
-25
-26
-27
-25
-23
-33
-35
EBITDA
-29
-21
-24
-25
-25
-26
-25
-19
-32
-33
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunic Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-52
-42
-37
-48
-91
-119
-99
-98
-103
EBITDA
-51
-15
-36
-48
-92
-86
-93
-100
-97
Interest Expense
-
-
0
-
-
1
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-41
-34
-44
-92
-120
-93
-100
-97
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
-52
-41
-34
-44
-92
-120
-93
-100
-97
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunic Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Operating Cash Flow
-23
-17
-20
-22
-21
-24
-20
-19
-17
-30
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
74
-
-
0
-
65
-
0
188
0
Change in Cash
50
-17
-20
-23
-21
41
-20
-19
171
-31

Immunic Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-52
-41
-34
-44
-92
-120
-93
-100
-97
Operating Cash Flow
-40
-43
-28
-46
-83
-65
-70
-84
-85
Investing Cash Flow
0
0
10
0
0
-9
9
0
0
Financing Cash Flow
37
0
34
144
42
95
1
74
65
Change in Cash
-3
-43
16
98
-40
19
-60
-11
-20

Mutual Funds that own Immunic Stock

Check out the Mutual Funds with significant holdings in Immunic.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
8.386443%
1142358
SCHWAB CAPITAL TRUST
0.062401%
8500
Victory Portfolios III
0.029181%
3975
Fidelity Salem Street Trust
0.013787%
1878

Global Institutional Holdings in Immunic

Funds
Holdings
Michael Rockefeller
7.1%
Vanguard
4.1%
iShares
0.35%
Kenneth Tropin
0.24%
Simplify
0.23%

Insights on Immunic

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, IMUX stock has moved up by 37.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 616.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 417.8%

About Immunic

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
OrganisationImmunic
Headquarters1200 Avenue of the Americas, New York, NY, United States, 10036
IndustryBiotechnology
CEOMr. Jason Tardio M.B.A.
E-voting on sharesClick here to vote

Key Management of Immunic

Name

Title

Mr. Jason Tardio M.B.A.

COO & President

FAQs

What is Immunic share price today?

Immunic share price today is $16.84 as on at the close of the market. Immunic share today touched a day high of $17.15 and a low of $15.88.

What is the 52 week high and 52 week low for Immunic share?

Immunic share touched a 52 week high of $16.86 on and a 52 week low of $5.06 on . Immunic stock price today i.e. is closed at $16.84,which is 0.13% down from its 52 week high and 232.67% up from its 52 week low.

What is Immunic's market capitalisation today?

Immunic market capitalisation is $0.00T as on .

How to invest in Immunic Stock (IMUX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunic on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunic Shares that will get you 0.0891 shares as per Immunic share price of $16.84 per share as on August 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Immunic Stock (IMUX) from India?

Indian investors can start investing in Immunic (IMUX) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Immunic stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunic share’s latest price of $16.84 as on August 19, 2026 at 1:29 am IST, you will get 0.5938 shares of Immunic. Learn more about fractional shares .

What are the returns that Immunic has given to Indian investors in the last 5 years?

Immunic stock has given -83.34% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?